 |
| Modules | |
| Google | |
|
These ads help pay for the upkeep of our site. They are automatically served by Google and are not affiliated with This is MS. | |
| Languages | |
|
Select Interface Language:
| |
| Who's Online | |
There are currently, 182 guest(s) and 15 member(s) that are online.
You are Anonymous user. You can register for free by clicking here | |
| Next Step | |
| Donations | |
|
To remain unbiased, This is MS does not accept corporate sponsorships. Therefore, we must rely on our users to help support us. Please donate to our upkeep if you have the means. Thank you! | |
| |
 | Biogen Buys Another Promising MS Drug (BG-12) |
 Just days after jointly announcing promising results in Phase II MS trials of an oral compound known as BG-12, Biogen Idec has bought the therapy's creator, Fumapharm of Switzerland.
BG-12, in a double-blind, placebo controlled trial with over 250 patients, demonstrated a 69% reduction in active lesions versus placebo between months 3 and 6 after starting the therapy. There was a 48% decrease in new T2 lesions (T2 lesions are plaques that are generally considered to be a marker of overall disease activity in the past year). A 32% reduction...
story continues, please click "read more"
|
|
|
Posted by Administrator on Thursday, June 01 @ 16:42:33 EDT (4570 reads)
(Read More... | 14078 bytes more | Score: 3)
|
|
| |
| Login | |
|
Don't have an account yet? You can create one. As a registered user you have some advantages like theme manager, comments configuration and post comments with your name. | |
| Survey | |
| Big Story of Today | |
|
There isn't a Biggest Story for Today, yet. | |
| Old Articles | |
|
There isn't content right now for this block. | |
| Latest Forum Posts | |
| Information | |
|
This site is privately funded by individuals interested in fighting multiple sclerosis.
There are no corporate grants, medical center affiliations, or overbearing advertisements, providing a truly independent online community for MS.
Note that all medical decisions should be made with the consent of your doctor. | |
|
|
